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Characterization of a dual function macrocyclase
enables design and use of efﬁcient
macrocyclization substrates
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Peptide macrocycles are promising therapeutic molecules because they are protease resis-
tant, structurally rigid, membrane permeable, and capable of modulating protein–protein
interactions. Here, we report the characterization of the dual function macrocyclase-
peptidase enzyme involved in the biosynthesis of the highly toxic amanitin toxin family of
macrocycles. The enzyme ﬁrst removes 10 residues from the N-terminus of a 35-residue
substrate. Conformational trapping of the 25 amino-acid peptide forces the enzyme to
release this intermediate rather than proceed to macrocyclization. The enzyme rebinds the
25 amino-acid peptide in a different conformation and catalyzes macrocyclization of the N-
terminal eight residues. Structures of the enzyme bound to both substrates and biophysical
analysis characterize the different binding modes rationalizing the mechanism. Using these
insights simpler substrates with only ﬁve C-terminal residues were designed, allowing the
enzyme to be more effectively exploited in biotechnology.
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Cyclic peptide macrocycles hold promise in pursuing chal-lenging targets involved in protein–protein interactionsimplicated in diseases as diverse as cancer and anti-
microbial infections1. Due to their constrained, pre-organized,
and protease-resistant structures, these molecules can modulate
key complex macromolecular interactions in a manner that has
proven extremely difﬁcult for conventional small molecules1, 2. In
contrast to most linear peptides, many peptide macrocycles are
highly cell permeable3. Ribosomally synthesized and post-
translationally modiﬁed peptides (RiPPs) are a particularly
attractive class of macrocycles because their enzymatic synthesis
is driven by enzymes working in cascade to process a genetically
encoded and highly variable peptide precursor4. The peptide
precursor can be modiﬁed by macrocyclization, oxidation, het-
erocyclization, hydroxylation, and prenylation in a predictable
and scalable manner5. The patellamide pathway is a paradigm in
this system, in which catalysis and recognition are physically
separated in many of the enzymatic steps leading to a unique
combination of speciﬁcity and promiscuity6. The macrocyclase in
the patellamide biosynthetic pathway (PatGmac) belongs to the
subtilisin class of proteases, requiring a substrate with a C-
terminal AYD motif, preceded by heterocyclized cysteine or a
proline residue7, 8. The enzyme is otherwise almost insensitive to
the core sequence that becomes the macrocycle and only the
thiazoline (or proline) are part of the ﬁnal product, as the AYD is
cleaved off during the reaction. This combination of speciﬁcity
through the use of disposable tags (leader and/or tail sequences)
and promiscuity in the core sequence produces a system that is
almost inﬁnitely variable. This has made RiPPs appealing for
exploitation in biotechnology. In some RiPPs systems, a linker
that can also be varied in both length and composition separates
the recognition tag and core peptide9, 10. Despite the appeal of
their promiscuity, the PatG family of macrocyclases face a severe
drawback as they are slow11, 12, although in vitro addition of
reductant does increase catalytic efﬁciency13.
In addition to PatG, there are four other broad classes of
peptide macrocyclases12, 14–16 that operate through an acyl
enzyme intermediate. The sortase class of enzymes, which cata-
lyze transpeptidation by recognizing a C-terminal LXPTG
motif17, the butelase enzyme, which is an asparagine/aspartate
(Asx) peptide ligase18, the NRPS thioesterases19 and the prolyl
oligopeptidase (POP) class of enzymes. A further important class
of macrocyclases is that of the ATP-grasp superfamily, which as
the name suggests rely on ATP hydrolysis to drive macrocyclia-
tion20. The enzymes that catalyze close to traceless peptide bond
formation regardless of the peptide sequence—, i.e., only one
residue from the precursor peptide recognition tag is carried over
to the ﬁnal cyclic product—are PatGmac family members, bute-
lase, and POP macrocyclases. The POPB from Basidiomycete
fungi such as Amanita bisporigera and Galerina marginata
(GmPOPB) species have been reported as having kcat values
comparable to butelase, the fastest rate observed for peptide
macrocyclisation15, 21. GmPOPB is the macrocyclase responsible
for macrocyclization of amatoxins, eight amino-acid ribosomal
peptides with the core sequence IWGIGC(N/D)P. Amatoxins are
cyclic peptides further modiﬁed by a characteristic sulfoxide
cross-link between tryptophan and a cysteine (Fig. 1a), and
hydroxylation (the extent of which vary). The genomes of G.
marginata and other amatoxin producing Amanita species pos-
sess more than 50 gene sequences annotated as AMA1 (amatoxin
precursors) in which there is considerable diversity in the long C-
terminal tail that follows the core sequence15, 22. Amatoxins are
the cause for the toxicity of Amanita and Galerina mushrooms.
They are readily absorbed through the gut, and a lethal dose in
adults is <10 mg23. Amatoxins are stable to inactivation by either
the mammalian digestive tract or cooking, thus consumption of
even small numbers of such mushrooms is often fatal. Amatoxin
toxicity arises from its accumulation in the liver where it inhibits
RNA polymerase II leading to irreparable liver failure23. The
highly stable and potent toxicity of amatoxins has led to their
exploration as warheads for targeted cancer therapy24, 25. The
amatoxin peptide precursor is produced as a 35 amino-acid linear
substrate (Fig. 1b), which is ﬁrst processed to a 25 residue peptide
(25mer) by removal of the highly conserved 10 N-terminal
amino-acid leader26 that is discarded. The newly exposed N-
terminal eight residues of the 25mer product are then macro-
cyclized and the tail, which is necessary for macrocyclization, is
discarded (Fig. 1c). Remarkably, both proteolysis and macro-
cyclization steps are carried out by the same enzyme, GmPOPB15.
We report the functional and structural characterization of
GmPOPB and establish the molecular features that determine
whether the enzyme catalyzes proteolysis or macrocyclization.
Informed by structural and biophysical studies, we have designed
a much simpler substrate with fewer C-terminal residues that can
be macrocyclized by GmPOPB at synthetically useful rates. The
shorter substrate is more cost effective to produce by solid-phase
chemical synthesis allowing the generation of more chemically
diverse macrocycles, a valuable biotechnological tool.
Results
Structural biology of Apo and substrate-bound GmPOPB. The
apo protein crystals belong to space group P212121, with one
monomer in the asymmetric unit. The structure was determined
at 2.4 Å resolution by molecular replacement using the β-
propeller domain of the proline oligopeptidase from porcine
brain (residues 82–450, PDB:1h2z) as search model. The reﬁned
apo model (PDB:5N4F) includes residues 7–222, 230–695, and
704–726, and the missing regions are presumed to be disordered
portions of the protein. The protein contains two domains as
observed in other POP enzymes27. The domain containing the
putative catalytic residues (Ser577, Asp661, His698) comprises
residues 1–81 and 450–728, and the other domain is a seven
bladed β-propeller, comprising residues 82–449 (Fig. 1d). In the
apo structure, the two domains are in an “open” conformation, in
an arrangement reminiscent of a hinged lid on a bottle. This open
conformation has been observed in other POPs in crystal form
when free of ligand28, 29. The catalytic serine sits at the tip of a
loop and points toward the β-propeller domain (Supplementary
Fig. 7). The side chain oxygen of Ser577 is 5.6 Å from the side
chain carboxylate of Asp661; His698 is on a loop that is dis-
ordered. Ser577 and Asp661 of GmPOPB occupy the same
position as Ser554 and Asp641 in the porcine proline oligo-
peptidase structure30.
In order to obtain co-complexes, we mutated each residue of
the presumed catalytic triad (mutants S577A, D661A, and
H698A) to ensure inactive protein. Crystals were obtained for
the 35mer complex for S577A and H698A; with the 25mer
substrate S577A and D661A (Table 1). GmPOPB-S577A (the
higher resolution of the pair) bound to the full-length substrate
(35mer) belongs to space group P21 with four monomers in the
asymmetric unit. For ease of discussion, we split the 35mer into
four regions (Fig. 1b), the 10 residue leader (residues 1–10), the 8
residue core (11–18), 6 residue linker (19–24), and the 11 residue
recognition tail (25–35). The reﬁned model (PDB:5N4C) includes
residues 6–225 and 228–727 of the protein and residues 3–35 of
the peptide (Fig. 1c). The same inactive mutant of GmPOPB was
used to obtain a complex structure with the 25mer substrate; it
comprises core (residues 1–8), linker (9–14), and recognition tag
(15–25). The reﬁned model includes residues 4–727 of the protein
and residues 9–25 (linker and recognition tag) of the peptide
(PDB:5N4B). Although we observed residual difference electron
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density for the N-terminal residues of the 25mer, we were unable
to satisfactorily model it. To observe interactions when the
catalytic residue Ser577 is present, we also obtained complex
structures of the H698A mutant bound to the 35mer peptide
(PDB:5N4E) and the D661A mutant bound to the 25mer peptide
(PDB:5N4D).
In all 35mer and 25mer complexes, the enzyme adopts the
same “closed” conformation in which the lid (the propeller
domain) sits on top of the catalytic domain (Fig. 1e). In both
25mer complexes the N-terminal residues of the substrate
(IWGIGCN) are disordered; in the S577A–35mer complex the
N-terminal two residues (MF) are missing, while in the H698A
complex only the ﬁrst N-terminal residue is absent. There are no
large differences between the protein backbone positions in the
complexes with the 35mer and 25mer substrates (root mean
square deviation (rmsd) of 0.48 Å over 720 Cα positions for the
S577A structures). There are also no major differences between
the H698A–35mer and S577A–35mer complexes, and between
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Fig. 1 Amanitin biosynthesis and the role of GmPOPB. a Biosynthesis of α-amanitin from the cyclic peptide produced by GmPOPB involves oxidation (blue
circle), hydroxylations (purple circles), and cross linking (green circle). Amino acids in the cyclic peptide are depicted as geometrical shapes, and the core
proline is labeled. b 35mer substrate used by GmPOPB to catalyze peptide bond hydrolysis and macrocyclization. Peptide is divided in four regions, leader
(blue), core (light gray), linker (magenta), and tail (orange). The color coding for peptide regions for c, e–g follows this. c Scheme of the reactions catalyzed
by GmPOPB. d ApoGmPOPB in an open state showing 22 Å separation between the β-propeller (dark green) and the peptidase domain (light green). e
Overlay of 25mer (blue) and 35mer (green) complexes of S577A. Separation between domains is reduced to 4 Å when peptide is bound. 35mer peptide is
shown in spheres. Darker colors show the β-propeller domain, while light colors show the peptidase domain. f 35mer peptide bound to GmPOPB-S577A
showing electron density (2Fo—Fc contoured at 1σ level in gray mesh) for peptide. g 25mer peptide bound to GmPOPB-S577A showing electron density for
peptide (2Fo—Fc contoured at 1σ level in gray mesh). Supplementary Fig. 11 contains a stereo image depicting electron density maps for the 25mer and
35mer peptide complexes
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the S577A–25mer and D661A–25mer complexes. Table 1 shows
the data collection and reﬁnement statistics for all structures. The
recognition tail adopts an identical distorted 310 helix conforma-
tion inserted into the middle of the β-propeller domain in both
the 25mer and 35mer complexes (Fig. 1f, g and 2). The carboxyl
terminus sits in a pocket where it makes water-mediated
hydrogen bonds to the protein. To our surprise, there are only
a few hydrogen bonds between the protein and the tail (Fig. 2c for
the S577A–25mer complex and Fig. 2d for the S577A–35mer
complex). Comparison to the apo structure reveals that binding
of substrate induces no signiﬁcant changes in the core of the
propeller domain (rmsd of 0.75 Å over 360 Cα positions for the
S577A structures). The changes that occur (relative to the apo
structure) are in loops around the catalytic site.
Signiﬁcant differences between the two substrates are observed
for the residues of the linker region, since it occupies distinct
conformations on the 25mer and 35mer complexes (Fig. 2b). V24
faces Arg79 and V14 is toward Phe506. H23 does not form any
hydrogen bonds, while H13 is hydrogen bonding with Glu601.
Tyr494 is within hydrogen bonding distance from E22, while on
the 25mer complex Tyr494 is interacting with W9. This peptide
twisting causes a tryptophan present in the peptides from both
complexes (residue 19 in 35mer, 9 in the 25mer), C-terminal to
the site of cleavage, to occupy a binding pocket close to the active
site. The oxyanion-stabilizing Tyr496 is in close proximity to the
core proline (P8) in the 25mer structure (D661A mutant), while
Tyr496 hydrogen bonds with P18 in the 35mer complex (Fig. 2d).
Substrate residues I11–P18 (the core peptide is not seen in the
25mer, apart from weak density from P8 in the D661A–25mer
complex) form a twisted loop, which makes contacts with the
protein and within itself; atoms that will ultimately form the
macrocycle are 7.6 Å apart (Fig. 2d). The core peptide interposes
between substrate P18 and enzyme Ser577, which is over 8 Å
away. Substrate P10, the site of proteolytic cleavage, is positioned
for attack by Ser577 (the Cβ of the mutated residue is 3.3 Å from
the carbonyl with plausible geometry). In the crystal structure of
H698A–35mer complex, the hydroxyl of Ser577 is in hydrogen
bonding distance from P10, in a position suited for nucleophilic
attack but the structure is less ordered, notably the loop
containing the mutation H698A. Tyr496 is on the opposite face
of the carbonyl 2.8 Å from the oxygen and positioned to stabilize
the tetrahedral intermediate from attack of Ser577 (Fig. 2d). Both
the interaction and the role of Tyr496 are conserved in other
POPs. In the 35mer complex structures, residues 2–9 adopt a
helical arrangement that ends up exposed to solvent at the N-
terminus and makes few contacts with the protein (Fig. 2d). In
none of the GmPOPB structures that we have obtained are the
catalytic residues arranged in the traditional manner, the closest
approach of the His698 and Ser577 is 13 Å and residues block
simple movement (Supplementary Fig. 7). To conﬁrm the
importance of the putative catalytic triad for GmPOPB, the
mutants S577A, D661A, and H698A were evaluated for activity,
and were inactive with both 25mer and 35mer substrates, using
5 μM GmPOPB and monitoring the reaction progress after 24 h.
Mutations in the histidine loop decrease enzyme activity. To
study other residues involved in hydrolysis and macrocyclization,
additional mutants H698N, R663A, R663Q, R663K, and W695Δ
(deletion) were generated. These mutants were designed based on
comparison of sequence alignments between other POP enzymes
and the very similar POPA enzyme from G. marginata, enzymes
that solely act as proteases. Arg663 is highly conserved in POPs
and thought to play a role in catalysis or substrate binding, since
it makes hydrogen bonds with the peptide substrate31. Supple-
mentary Fig. 9a depicts a sequence alignment comparing POPA,
POPB, PCY1 (another macrocyclase from the prolyl oligopepti-
dase family), and porcine POP while Supplementary Fig. 9b
Table 1 Data collection and reﬁnement statistics
GmPOPB-
S577A_25mer
GmPOPB-
D661A_25mer
GmPOPB-
S577A_35mer
GmPOPB-
H698A_35mer
apo_GmPOPB
Data collection
Space group P 21 21 21 P 21 21 21 P 21 P 21 21 21 P 21 21 2
Cell dimensions
a, b, c 99.1, 114.7, 141.3 99.0, 114.9, 141.3 100.8, 142. 6, 116.4 99.2, 115 141. 5 90.89, 105.62, 86.96
α, β, γ 90.0, 90.0, 90.0 90.0, 90.0, 90.0 90.0, 90.29, 90.0 90.0, 90.0, 90.0 90.0, 90.0, 90.0
Resolution 1.44 (1.49–1.44) 1.62 (1.678–1.62) 2.19 (2.268–2.19) 2.9 (3.0–2.9) 2.4 (2.49–2.4)
Unique reﬂections 288,485 (28,320) 204,059 (20,188) 163,136 (16,107) 32,664 (1690) 31,441 (2534)
Completeness (%) 99.7 (99) 100 (100) 97 (96) 97 (93) 99 (77)
Mean I/sigma (I) 9.3 (1.3) 6.9 (1.0) 6.7 (1.2) 6.8 (1.7) 14.5 (2.2)
R-merge 0.114 (1.01) 0.059 (0.69) 0.112 (1.0) 0.068 (0.53) 0.029 (0.56)
R-meas 0.063 (0.588) 0.084 (0.98) 0.27 (1.5) 0.096 (0.52) 0.036 (0.72)
Redundancy 6.0 (6.6) 6.7 (6.6) 2.0 (2.0) 1.8 (1.6) 5.1 (3.3)
Reﬁnement
Resolution range 43.3–1.44 46.9–1.62 82.3–2.19 32.0–2.9 45.44–2.4
Reﬂections used in reﬁnement 288,428 (28,313) 203,960 (20,185) 163,135 (16,107) 32,664 (1690) 31,437 (2534)
Rwork/Rfree 0.17/0.19 0.20/0.23 0.23/0.26 0.255/0.303 0.21/0.25
Protein residues 1478 1478 3014 1484 703
RMS(bonds) 0.015 0.020 0.012 0.007 0.007
RMS(angles) 1.28 1.82 1.42 1.10 1.17
Ramachandran favored (%) 97 97 97 97 97
Ramachandran allowed (%) 2.5 2.5 3.1 2.9 2.3
Ramachandran outliers (%) 0.14 0.3 0.3 0.48 0.29
Rotamer outliers (%) 0.24 1.4 0.95 1.1 0.34
Clashscore 3.73 1.63 1.02 3.42 2.64
Average B-factor 15 21 15 32 44
Macromolecules 14 20 14 34 43
Solvent 27 31 43 37 38
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depicts the position of these residues in GmPOPB. H698N was
insoluble and not evaluated. The other mutants possessed
diminished activities for both peptide bond hydrolysis and
macrocyclization. The amount of cyclic peptide present after
incubation for 16 h with the 25mer substrate was R663Q>
R663A>W695Δ> R663K. When the 35mer was used as sub-
strate, the mutants demonstrated diminished activity for peptide
bond hydrolysis and almost undetectable activity for macro-
cyclization (Supplementary Fig. 9c).
Kinetic characterization and substrate scope of GmPOPB.
Previous analysis employed GmPOPB isolated from the G.
marginata mushroom after transformation with Agrobacterium
tumefaciens15. We examined kinetic parameters and performed a
substrate speciﬁcity study on the enzyme isolated employing a
bacterial overexpression system. Substrates tested are shown in
Supplementary Fig. 1. Our results on the native overexpressed
enzyme conﬁrm the previous ﬁndings15 obtained for protein
puriﬁed from mushroom that the full-length 35mer substrate is
cleaved and the resulting 25mer is released (Supplementary
Fig. 3). The kinetic data for expressed protein with the 25mer but
not 35mer have been previously reported15, 21. The 25mer then
rebinds (in competition with the 35mer) for macrocyclization.
Cleavage and macrocyclization do not occur in a single binding
event15. The 25mer accumulates as an intermediate although the
proteolysis reaction is slower than cyclic peptide formation
(Supplementary Fig. 2). Very similar values for Km and kcat were
obtained for all full-length substrates evaluated, with Km values
ranging from 8 to 51 μM, while kcat was between 3.2 and 35 min−1
(Supplementary Fig. 2; Supplementary Table 2). Conservative
amino-acid substitutions within the peptide substrate had no
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Fig. 2 Interactions between GmPOPB and linker regions for 35mer and 25mer substrates are different. a Overview of bound peptides. Colors for distinct
peptide regions are as in Fig. 1b, except that the linker in the 25mer complex is in dark gray. Position of the catalytic Ser577, and core and leader proline
residues (yellow) are indicated in sticks. b Comparison of the linker region between 35mer (magenta) and 25mer (gray) complexes. Highlighted are the very
different position of Glu and His in contrast to tryptophan, which in both structures occupies the same pocket although the conformation is different. c
Interactions between peptide tail and linker of the 25mer peptide and GmPOPB-S577A. Residues within hydrogen bonding distance are shown in lines,
residues participating in hydrophobic interactions are in spheres, water molecules are depicted as small red spheres, prolines are shown in yellow. Color
coding for peptide substrate regions follows a, residues from GmPOPB are depicted in blue. d Interactions between peptide tail, linker, core, and leader
(anti-clockwise) of the 35mer peptide and GmPOPB-S577A. The same representation as c is used except residues from GmPOPB are depicted in green
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effect either on kinetic parameters or yield of cyclic product. Less
conservative substitutions such as mutation to alanine or 9mer
core (IWGIGCANP the bold underlined residue represents the
insertion) led to reduced macrocyclization and increased linear
peptide, the product of peptide hydrolysis instead of macro-
cyclization (Supplementary Fig. 8).
Equilibrium binding of substrates and products. Binding of the
inactive mutant S577A to the 25mer, 35mer, a series of truncated
substrates (10mer–14mer), as well as the recognition sequence
(17mer) WTAEHVDQTLASGNDIC, the truncated recognition
sequences VDQTLASGNDIC and TLASGNDIC, and the
leader peptide MFDTNATRLP were evaluated by isothermal
titration calorimetry (ITC). The results of S577A with both the
25mer and recognition sequence have previously been reported21.
Binding of H698A to the 25mer was also measured. The only
peptide showing no detectable binding at concentrations up
to 1 mM was the 10-residue leader peptide MFDTNATRLP.
The full-length substrates and products displayed tight binding
(Kd-25mer–S577A= 67± 14 nM21, Kd-25mer–H698A = 47± 11 nM,
Kd-35mer= 120± 30 nM, Kd-recognition= 430± 10 nM21; binding is
dominated by enthalpic contributions (Supplementary Fig. 6b)
(Fig. 3a shows representative ITC traces for the 13mer and 14mer
substrates, Fig. 3b shows Kd values for all peptides evaluated,
Supplementary Fig. 10 shows raw data for all binding curves).
The inactive mutant H698A has identical Kd-25mer to the S577A
mutant suggesting the lack of activity results from catalytic
incompetence rather than disruption of substrate binding.
Interestingly, despite being longer and having the potential for
more interactions with the protein, the 35mer peptide shows
slightly weaker binding compared to the 25mer, mostly due to
decreased ΔH. A comparison of the complex structures shows
that in the 35mer complex there is disorder of side chains in the
segment TAEHVD (linker region) but not in the 25mer. To
investigate the role of recognition tag peptides corresponding to
the entire recognition sequence (linker plus tail, WTAEHVDQ-
TLASGNDIC—17 residues), the recognition tail plus the valine
from the linker (VDQTLASGNDIC 12 residues) and the highly
conserved portion of the tail (TLASGNDIC 9 residues) were
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bars are standard error of the mean from the average of at least two independent measurements (Supplementary Table 3). c Michaelis–Menten curves
show both the 13mer and 14mer are substrates for the enzyme. Fitted values for Kd, Km, and kcat are shown in Supplementary Tables 2 and 3. Error bars are
standard error of the mean from duplicate measurements. d Cyclic peptide produced after 1 h reaction with 1 μM GmPOPB and 200 μM of various peptide
substrates. e Peptide produced after 16 h of reaction with 1 μM GmPOPB and 200 μM of various peptide substrates. Peptide sequences are colored as
Fig. 1b and detailed in Supplementary Fig. 1
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tested for binding and gave Kd-17mer–recogSeq= 0.43± 0.01 μM21,
Kd-12mer–recogSeq= 5± 1 μM and Kd-9mer–recogSeq= 121± 19 μM
(Supplementary Table 3; Supplementary Figs. 6 and 10). Pre-
viously, we showed that the recognition sequence dominates
binding, with a difference in ΔG of only 1.34 kcal mol−1 between
the 17mer recognition sequence and the 25mer peptide21. To
explore how much contribution to the binding energy comes
from the linker region, we evaluated the binding of truncated
recognition sequences. Our data show that the linker region is
important in binding as the loss of the linker (shrinking the
recognition sequence from 17 to 12 amino acids) reduces binding
afﬁnity 20-fold. On its own, the highly conserved nine-residue tail
bound rather weakly, consistent with the few interactions
observed with the protein. Following from this ﬁnding, a series of
truncated peptides (core plus parts of the linker) were tested and
revealed a trend in which binding afﬁnity increased from 10mer to
13mer (Kd-10mer= 83± 17 μM, Kd-11mer= 39± 18 μM, Kd-12mer= 21
± 5 μM, Kd-13mer= 2.4± 0.1 μM) peptides, but decreased slightly with
the 14mer peptide (Kd-14mer= 9.5± 1.1 μM) (Fig. 3b); the 9mer was
not sufﬁciently soluble for analysis. We noted that the difference
in afﬁnity between the 35mer and the core plus linker (13mer)
was ~20-fold.
Discussion
GmPOPB can form and hydrolyze peptide bonds depending on
the substrate length and structure. Both reactions proceed by
similar chemical mechanisms, passing through an acyl enzyme
intermediate. Typical POPs catalyze peptide bond cleavage fol-
lowing a proline, and less efﬁciently an alanine, showing strong
preference for substrates shorter than 30 amino acids32.
GmPOPB is unusual in that it processes a 35 amino-acid sub-
strate, the longest observed for a POP. POP enzymes possess an
aspartate, histidine, and serine catalytic triad. Molecular dynamic
simulation studies comparing the porcine and bacterial POPs
have proposed a mechanism in which inter-domain “breathing” is
required for catalysis33. Although structures of apo and POPs
bound to short peptide substrates and inhibitors (ranging from
230 to 7 amino acids34) are available, no substrate complex with a
long peptide has previously been determined. Interestingly, in
GmPOPB complexes the residues of the presumed catalytic triad
are not aligned. His698 is 12 Å away (much further than in any
other POP, Supplementary Fig. 7) from Ser577 but is essential for
catalysis rather than binding. The enzyme–substrate complex
shows that, apart from His698, there is no other residue in
proximity to the active site capable of acting as general acid/
general base with pKa values near to the 8.0 measured from
kinetic analysis21. The domain breathing motion similar to, but
larger than, other POPs could correctly position the His698.
Mutations of the highly conserved Arg663 and deletion of Trp695
(an insertion relative to other POPs, Supplementary Fig. 9a),
which we predicted would affect loop structure and dynamics,
were severely compromised in activity with both 25mer and
35mer substrates, consistent with our prediction. We cannot,
however, exclude the possibility that His698 may be required for
positioning toward a productive conformation of the
enzyme–substrate complex rather than act as a base per se. The
histidine loop is disordered on the H698A mutant structure and
the H698N mutant is insoluble, hinting at a stabilizing role for
His698. Analogous to lipid acyl hydrolases35, the enzyme would
function with a catalytic dyad in which Ser577 is activated by a
water molecule bridged to Asp661.
Comparison of the three-dimensional structures of the enzyme
in complex with 25mer and 35mer substrates reveals only
minor rearrangements of the protein, mostly in loops that
accommodate the longer substrate. Both 35mer (proteolysis) and
25mer (macrocyclization) substrates bind to GmPOPB with high
afﬁnity driven mainly by enthalpy (Fig. 3b, Supplementary Fig. 7;
Supplementary Table 3). Consistent with the observation of
similar binding afﬁnities of the 25mer and 35mer (Kd 67
and 120 nM, respectively)21, the 10-residue leader (only
present in 35mer) does not bind. In both the 25mer and 35mer
complex structures, the recognition tail (C-terminal 11 residues)
is embedded deeply into the β-propeller domain in an
essentially identical arrangement. The linker region, however,
adopts very different arrangements in the two complexes,
thus its interactions with the protein are quite distinct in the
two structures (Fig. 2). ITC measurements show that the
linker region, particularly the portion following the core
peptide, makes substantial contribution to the binding energy.
This is in contrast to the heterocyclase class of RIPP enzymes,
where the linker plays no role and can be varied36. Our data show
that the structure of the linker is important in binding
and determines the orientation of the substrate at the active site
(thus its fate).
25mer
natural
substrate
Shorter
designed
substrate
5 amino acids
Macrocyclic
peptide
Macrocyclic
peptide
Recog.Seq
Recognition
sequence
release
17 amino acids
25mer
binding
Macrocyclization
Cyclic
peptide
release
25mer
25mer25mer linker
rearrangement
25mer
release
(unreactive)
Leader
release
Peptide bond
hydrolysis
Leader
35mer
35mer
binding
ba
Fig. 4 GmPOPB catalyzes peptide bond hydrolysis and macrocyclization. a The sequence of events catalyzed by GmPOPB starting with the 35mer peptide
substrate. Peptide bond hydrolysis yields the leader sequence (which dissociates) and the 25mer peptide. The enzyme-bound 25mer is conformationally
trapped and macrocyclization cannot proceed. The 25mer must dissociate to rearrange and re-bind only then does macrocyclization occur. Apo enzyme is
shown in gray, the enzyme functioning as a protease is colored green, and functioning as a macrocyclase in blue. The peptide is colored as Fig. 1b. b A 25mer
substrate yields a 17 amino-acid by-product, whereas the 13mer substrate generates a 5 amino-acid by-product, a much more economically efﬁcient
reaction. Substrates are colored as Fig. 1b
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Previous kinetic assays and ours reveal that after removal of the
leader, the remaining 25mer is released from GmPOPB, then it
rebinds and undergoes the macrocyclization reaction15. In the
35mer complex, the core and linker adopt a tightly packed
arrangement that is wedged between the active site loops. We
conclude that the linker and/or core are unable to refold to the
conformational arrangement seen in the 25mer complex
(required for macrocyclization) in situ on a timescale comparable
to dissociation. We propose the arrangement of and interactions
between C-terminal 25 residues and protein that are seen in the
35mer complex act as a kinetic trap, which can only be escaped by
dissociation (Fig. 4a). Conformationally trapped peptide reaction
intermediates have been identiﬁed in other systems. For example,
inhibition of proteases by serpins is accomplished by a suicide
substrate mechanism, in which the complex is trapped in an
inactive arrangement37.
Having identiﬁed the key role of the linker, we predicted that it
should be possible to design simpler macrocyclization substrates
that lacked the recognition tail. This would be valuable since the
use of 25mer substrates to make eight residue macrocycles is not
economic. ITC shows a 10-fold reduction in binding from 35mer
to 13mer, kinetic analysis reveals the 13mer substrate has a Km
(25 μM) within error to the 25mer substrate (50 μM), while the
14mer possesses higher Km (380 μM). Similar kcat values were
observed with both shorter substrates (0.49 and 0.58 min−1 for
the 13mer and 14mer, respectively, Fig. 3c; Supplementary
Table 2) but these are smaller than the 25mer (18 min−1). Linear
peptide (product of hydrolysis instead of macrocyclization) was
observed when shorter peptides were utilized as substrates
(Fig. 3d) consistent with the linker playing a key role in substrate
positioning. After 16 h of reaction both 13mer and 14mer sub-
strates produce similar amounts of macrocycle, but the 14mer
generates less linear product. Linear peptide produced this may
not be a signiﬁcant drawback, as puriﬁcation of macrocycles from
liner peptides is straightforward12, 38. Compared to PatG this
represents a signiﬁcant improvement, since biocatalytic reactions
with PatG in vitro can require over 7 days and utilize up to
stoichiometric amounts enzyme12, 38.
GmPOPB is an unusual enzyme catalyzing, depending on
substrate length, proteolysis, or macrocyclization using the same
catalytic machinery (Fig. 4a). Further complexity comes from the
fact that GmPOPB itself generates its 25 residue macrocyclization
substrate. The internal structure of the substrate is critical to how
the enzyme binds the substrate and to which reaction is catalyzed.
As a consequence of this requirement for a speciﬁc substrate
structure, the enzyme must release the 25mer peptide, allowing it
to refold rather than simply moving to the second reaction in a
processive manner. Previous work had identiﬁed the crucial
nature of the recognition sequence in the substrate, but suggested
its full length was a requirement for macrocyclization. Our
structural work supported by calorimetry and kinetics reveals that
shorter peptides are suitable substrates, if their design preserves
important interactions with the protein and maintains the peptide
structural recognition. GmPOPB recognizes residues within the
linker connecting the core and the recognition tail, and this
recognition is critical to position the substrate for macrocycliza-
tion. A substrate with ﬁve or six C-terminal residues (as opposed
to 17) chosen to mimic the linker can be efﬁciently macrocyclized
at synthetically useful rates (Fig. 4b). This work highlights the
power of structural and mechanistic studies to redesign substrates
or enzymes for use in biotechnology.
Note added in proof: Since the submission of this manuscript
two papers were published studying POPs, further demonstrating
the importance of this class of macrocyclase enzymes. One
reports the structure of the related PCY1 enzyme55 and the other
discusses broadening of the substrate proﬁle of GmPOPB56.
Methods
Materials. Peptides were purchased from Biosynthesis, as free amine and free
carboxylic acids, at a purity >90%. Buffers and chemicals, unless speciﬁed, were
from Sigma.
Expression of recombinant proteins. The plasmid pJExpress414 encoding the
codon optimized G. marginata POPB gene was purchased from DNA 2.0. Plasmids
were transformed into BL21(DE3) cells (Agilent). Cultures (50 mL) were grown
overnight at 37 °C in the presence of 100 μg/mL ampicillin, then diluted 100-fold
into 6 L Terriﬁc Broth (TB) media. These cultures were grown at 37 °C with
shaking (200 rpm) until the optical density at 600 nm (OD600) reached 0.6. Cells
were cooled down for 1 h to 16 °C, and protein expression was then induced by the
addition of 0.5 mM isopropyl β-D-thiogalactopyranoside (IPTG, Generon). Cul-
tures were incubated for an additional 16 h and centrifuged at 6000×g for
15 min. Cell pellets were resuspended in 250 mL Ni–NTA lysis/wash buffer A
(50 mM HEPES pH 8.0, 300 mM NaCl, 10 mM imidazole, 10% glycerol, and 2 mM
β-mercaptoethanol) supplemented with complete EDTA-free protease inhibitor
tablets (Roche Applied Science). The resulting suspension was lysed by two pas-
sages through a cell homogenizer at 30,000 psi, and puriﬁed by nickel chromato-
graphy. Each desired protein was eluted using a step elution with lysis buffer
supplemented with 250 mM imidazole (buffer B). Eluted protein was dialyzed
overnight against buffer C (50 mM HEPES (pH 8.0), 50 mM NaCl, 10% glycerol,
and 2 mM β-mercaptoethanol) while simultaneously the His-tag was cleaved by
TEV protease (prepared in house39). This dialyzed TEV-cleaved mixture was
loaded onto a Histrap column connected in tandem to a Hitrap Q-FF column. Both
columns were washed with buffer C, and GmPOPB was eluted during this wash.
Fractions were pooled and concentrated to <8 mL (at 10 mg/mL approximately).
Protein was loaded onto a Superdex S200 gel ﬁltration column (GE Healthcare)
pre-equilibrated with storage buffer D (50 mM HEPES (pH 8.0), 50 mM NaCl, 10%
glycerol, and 2 mM β-mercaptoethanol). Fractions containing pure protein were
combined, concentrated, divided in aliquots, ﬂash frozen, and stored at −80 °C.
Protein concentrations were determined by absorbance at 280 nm40.
Site-directed mutagenesis. Mutants S577A, D661A, H698N, R663A, R663Q,
R663K, and W695Δ were generated by a published mutagenesis protocol41. Oli-
gonucleotides for mutagenesis were purchased from IDT. Sequences of primers
used for mutagenesis and sequencing are given in Supplementary Table 1.
Sequencing was performed using at least three primers to cover the entire gene
sequence (Euroﬁns).
General procedure for kinetic assays. Comparison between distinct substrates
was performed in 50 mM Tris pH 8.0, 50 mM NaCl, 10 mM DTT with varying
concentrations of substrates at room temperature. All reactions were performed in
duplicates. Reactions were started by adding GmPOPB (50 nM for GmAMA1_C6S,
1 μM for the 13mer and 14mer, and 20 nM for other substrates) to the assay
mixture containing buffer and peptide. Reactions were quenched at several time
points by adding 50 μL reaction mixture to 20 μL 6% TFA. Reactants were sepa-
rated from products for quantiﬁcation by injecting 50 μL of each quenched time
point mix onto a ZORBAX SB-C18, 5 µm, 9.4 × 50 mm (Agilent) column con-
nected to an Agilent LC-MS (G6130B Single Quad, Agilent Technologies). Reac-
tants were separated from products using a gradient from H2O containing 0.1%
TFA or 0.1% formic acid and 5% acetonitrile to 50% acetonitrile,
at 1.5 ml/min for 8 min. Peaks with ultra violet (UV) absorbance at 220 and
280 nm were integrated, the area of peaks corresponding to reactant and products
was used to calculate the percentage of product formed after a correction for
differences in the extinction coefﬁcient of each peptide was applied (ε280–25mer=
11,000M−1 cm−1, ε220–25mer= 46,000M−1 cm−1, ε280–cyclic= 5500M−1 cm−1,
ε220–cyclic= 34,000M−1 cm−1, and ε280–tail= 5500M−1 cm−1). The sum of product
+substrate was assumed equal to the total initial amount of substrate, product
converted from % to concentration. This value was divided by concentration of
enzyme present to yield v/Et (min−1). When enzyme mutants and peptides con-
taining alanine in the core sequence were tested for activity, higher concentrations
5 μM enzyme and 100 μM substrate were incubated for 1 and 18 h at room tem-
perature. For progress curves with the 35mer substrate, measurements were tri-
plicate and quantiﬁcation relied on ion counts from mass spectrometry. Mass
signals corresponding to 35mer (1282.9 Da—M+3H), 25mer (900.7 Da—M+2H),
leader peptide (1165.5 Da—M+H), recognition sequence (930.4 Da—M+2H),
cyclic peptide (841.3 Da—M+H), linear peptide (859.4 Da—M+H) were mon-
itored, the area of each was integrated and quantiﬁed using a calibration curve
performed with the 25mer, 35mer, cyclic, and linear peptides as standards.
Authentic cyclic peptide was quantiﬁed by UV absorbance. Data showing products
formed after 1 and 16 h with truncated peptides were performed twice. UV and ion
count approaches gave similar results for the 25mer. Kinetic data were ﬁtted to a
Michaelis–Menten equation using GraphPad Prism, and values reported are
average and standard error of the mean.
Isothermal titration calorimetry. All titrations were performed on a MicroCal
PEAQ-ITC instrument (MicroCal, Malvern Instruments, Northamption, MA,
USA) and the results were ﬁtted with PEAQ-ITC analysis software (MicroCal,
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Malvern Instruments, Northampton, MA, USA). Peptide ligand solutions were
prepared in 20 mM Tris pH 8.0 containing 1 mM DTT, prior to buffer exchange by
three cycles of dilution in 50 mM Tris pH 8.0 with 50 mM NaCl, 10 mM DTT
followed by concentration using a Microsep Advance centrifugal device equipped
with a 1 kDa cut off membrane (Pall Corporation). The same three cycles of
dilution in 50 mM Tris pH 8.0 with 50 mM NaCl and 10 mM DTT followed by
concentration were performed with the protein to be used in the titration using a
Vivaspin protein concentrator spin column with a 30 kDa cut off (GE Healthcare).
A ﬁnal dilution to the concentration to be used for titration was performed using
the buffer that passed through during the protein buffer exchange, both for the
protein and peptide to be used to avoid any possible buffer mismatch. The stirred
cell contained 300 μL of protein (the inactive mutant GmPOPB_S577A at 20 μM
for 35mer, 36 μM for 10mer, 36 μM for 11mer, 29 μM for 12mer, 42 μM for 13mer,
29 μM for 14mer, 37 μM for 9mer recognition sequence, 21 μM for 12mer recog-
nition sequence), and the injection syringe contained 75 μL of peptide ligand (200
μM for 35mer, 924 μM for 10mer, 761 μM for 11mer, 484 μM for 12mer, 442 μM
for 13mer, 582 μM for 14mer, 1 mM for 9mer recognition sequence, 677 μM for
12mer recognition sequence). Titrations of peptide into protein solutions were
conducted at 20 °C. For all the titration experiments, a total of 19 injections of 2 μL
were made at 120 s intervals. The heat released due to the ﬁrst injection (0.4 μL)
was excluded from data analyses. Binding data with the H698A mutant were
performed by titrating enzyme (319 μM stock) into 25mer peptide (27 μM). Blank
runs in which peptide (or H698A) was titrated into buffer were performed to
correct for the heats of dilution and mixing, and the dilution isotherm for each
peptide ligand was subtracted from the respective binding isotherm prior to curve
ﬁtting. Equilibrium dissociation constants (Kd) as well as ΔH and ΔS values for
binding of each peptide to protein were obtained by ﬁtting the calorimetric data
with a single-site model using the stoichiometry parameter n ﬁxed at 1.0 using
Malvern PEAQ-ITC data analysis software. The ITC data for S577A with both the
25mer and recognition sequence (17mer) have previously been published21. We
performed all ITC binding experiments at least in duplicate, and calculations of
average and standard error of the mean were performed with GraphPad Prism.
Structural biology. ApoGmPOPB crystals were obtained by vapor diffusion at
20 °C using the hanging drop method. The initial conditions in the drop were
100 mg/mL GmPOPB, 30% PEG4000, and 100 mM MES buffer, pH 6.5. Several
crystal clusters appeared after incubation at 20 °C for 1 week, which were crushed
and used for microseeding using a 80 mg/mL GmPOPB solution and the same
precipitant. Crystals were cryoprotected by addition of 10% glycerol to precipitant
solution, and ﬂash cooled in liquid nitrogen. All complex structures were obtained
by vapor diffusion at 20 °C using the sitting drop method. Complexes with both
25mer and 35mer peptides were obtained by co-crystallization of 100 mg/ml
protein and two-fold molar excess of peptide, and contained 12.5 mM Hexammine
cobalt chloride as additive. For the S577A–25mer complex, crystals were obtained
with 28% PEG6000, 100 mM Bicine pH 9.0, 60 mM magnesium formate, and
2.42% DMSO. Crystals were cryoprotected by addition of 12% glycerol to pre-
cipitant solution, and ﬂash cooled in liquid nitrogen. For the D661A–25mer
complex, crystals were obtained with 28% PEG6000, 100 mM Tris pH 8.3, and
90 mM sodium/potassium phosphate. Crystals were cryoprotected by the addition
of 12% glycerol to precipitant solution, and ﬂash cooled in liquid nitrogen. Crystals
of S577A–35mer complex were obtained with 28% PEG6000, 100 mM Bicine pH
8.7, 64 mM sodium potassium phosphate. Crystals were cryoprotected by addition
of 12% glycerol to precipitant solution, and ﬂash cooled in liquid nitrogen. For the
H698A–25mer complex, crystals were obtained with 27% PEGMME2000, 90 mM
Bicine pH 8.7, and 100 mM potassium thiocyanate. Crystals were cryoprotected by
addition of 13% glycerol to precipitant solution, and ﬂash cooled in liquid nitrogen.
Data were collected at 100 K at the European Synchrotron Radiation Facility
(ESRF) beamline ID30A-3 (S577A–25mer complex), Diamond Light Source
beamlines I02 (apo GmPOPB), I04-1 (S577A–35mer complex), I03
(D661A–25mer), or in house on a Rigaku 007HFM rotating anode X-ray generator
with a Saturn 944 CCD detector (H698A–35mer). Data were processed with
HKL200042 (S577A–25mer and H698A–35mer complexes) or Xia2-DIALS43 (apo
GmPOPB, S577A–35mer and D661A–25mer complexes). All structures were
solved by molecular replacement with PHASER44, followed by density
improvement using PARROT45, then automatic building using Buccaneer46 and
Arp/wARP47. Manual rebuilding was performed with COOT48, and reﬁnement
was performed with REFMAC549 implemented in the CCP4 program suite50,
Phenix51, and PDB_REDO52. Structural ﬁgures were generated with PyMOL
(DeLano Scientiﬁc, LLC). In Fig. 4 the solution structures for 13mer, 25mer, and
35mer free were generated by PEPFOLD53, 54 and the macrocyclic peptide was
adapted from α-amanitin (PDB: 3CQZ).
Data availability. Sequences and plasmids for all clones used in this study have
been deposited on Addgene, with the following IDs: 92234 (GmPOPB-Wild type),
92235 (GmPOPB-S577A). 92236 (GmPOPB D661A), 92237 (GmPOPB-H698A),
92238 (GmPOPB-R663A), 92239 (GmPOPB-R663K), 92240 (GmPOPB-R663Q),
92241 (GmPOPB-W695Δ), and 92242 (GmPOPB-H698N). Coordinates have been
deposited in the Protein Data Bank, with accession codes 5N4B (S577A mutant
bound to 25mer peptide), 5N4C (S577A mutant bound to 35mer peptide), 5N4D
(D661A mutant bound to 25mer peptide), 5N4E (H698A mutant bound to 35mer
peptide), and 5N4F (apoGmPOPB). All the other data supporting the ﬁndings of
this study are provided within the article and supplementary ﬁles, and available
from the corresponding author upon reasonable request.
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